Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Laparoscopic Nephrectomy/Nephron Sparing Surgery (NSS)/Hynes-Anderson Procedures.

Sponsor
Medical University of Warsaw (Other)
Overall Status
Completed
CT.gov ID
NCT03874091
Collaborator
(none)
62
1
2
32.5
1.9

Study Details

Study Description

Brief Summary

62 patients age of 20 to 85, (ASA) physical status I-III undergoing laparoscopic nephrectomy/NSS/Hynes Anderson procedures in 1st Department of Anesthesiology in Warsaw will be enrolled in the study. Patients will be randomised into 2 groups - patients from the first group will undergo General Anaesthesia (GA) with intravenous analgesia peri-operatively, patients from the second group will receive GA plus the Erector Spinae Plane Block (ESP block) bilaterally performed under ultrasound guidance with catheter left on the side of surgery. Ultrasound transducer will be placed in a longitudinal orientation 3 cm lateral to the Th7 spinous process. Three muscles will be identified superficial to the hyperechogenic transverse process shadow as follows: trapezius, rhomboid major, and erector spinae. An 8-cm 18-gauge block needle will be inserted in a cephalad-to-caudad direction until the tip gets in the interfascial plane between rhomboid major and erector spinae muscles, as evidenced by visualization of local anesthetic spreading in a linear pattern between erector spinae and the bony acoustic shadows of the transverse processes. . Patients in this group will be anesthetized with 20ml 0,25% bupivacaine + Adrenaline 1:200 000 for each side. ESP block will be performed at the level of Th7-8 after proper positioning he patient in the sitting position before GA then standard technique of catheter application will be applied. After the surgery the elastomeric pump will be attached to the catheter with 0,125% bupivacaine with Adrenaline 1:200 000. Anaesthesia will be standardised In the both groups.

Condition or Disease Intervention/Treatment Phase
  • Procedure: bilateral ESP block with 0,25% Bupivacaine+ Adrenaline
  • Procedure: ESP block continuous infusion with 0,125% Bupivacaine+Adrenaline
  • Drug: Morphine PCA pump
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Laparoscopic Kidney Procedures
Actual Study Start Date :
Jan 15, 2019
Actual Primary Completion Date :
Sep 7, 2020
Actual Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: GA group

Patients will receive general anaesthesia for laparoscopic nephrectomy/NSS/ Hynes Anderson procedures. Analgesia will be provided by titration of fentanyl during surgery. An intravenous patient controlled morphine pump will be used postoperatively.

Drug: Morphine PCA pump
Morphine given postoperatively.

Experimental: ESP group

Patients will receive general anaesthesia with bilateral ESP block for laparoscopic nephrectomy/NSS/ Hynes Anderson procedures. Catheter will be inserted in the erector spinae plane on the side of surgery. Postoperatively patients will get continuous infusion of 0,125% Bupivacaine+Adrenaline to the catheter for 24h and PCA morphine pump intravenously.

Procedure: bilateral ESP block with 0,25% Bupivacaine+ Adrenaline
Regional anaesthesia technique performed under ultrasound guidance before surgery

Procedure: ESP block continuous infusion with 0,125% Bupivacaine+Adrenaline
Continous infusion of Local Anaesthetic (LA) given postoperatively via the catheter.

Drug: Morphine PCA pump
Morphine given postoperatively.

Outcome Measures

Primary Outcome Measures

  1. Postoperative Morphine Requirements [24 hours post surgery]

    Patient Controlled Analgesia (PCA) morphine consumption in both groups will be recorded.

Secondary Outcome Measures

  1. Intraoperative Fentanyl Requirements [Time of surgery.]

    Fentanyl consumption in both groups will be recorded

Other Outcome Measures

  1. Postoperative Nausea and Vomiting (PONV) [24 hours post surgery.]

    Postoperative nausea and vomiting will be recorded if occurred

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • pts undergoing laparoscopic nephrectomy/NSS/Hynes Anderson procedures in 1st Department of Anaesthesiology in Warsaw

  • pts consented for the study prior to surgery

  • ASA 1-3

Exclusion Criteria:
  • Pts without consent for trial

  • Pts ASA 4-5

  • Coagulation abnormalities

  • Allergy to local anesthetics

  • Skin lesions in the place of needle insertion

Contacts and Locations

Locations

Site City State Country Postal Code
1 Warsaw University Center Warsaw Poland 02-005

Sponsors and Collaborators

  • Medical University of Warsaw

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University of Warsaw
ClinicalTrials.gov Identifier:
NCT03874091
Other Study ID Numbers:
  • MedUnivLapESPblock
First Posted:
Mar 14, 2019
Last Update Posted:
Nov 16, 2021
Last Verified:
Mar 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Medical University of Warsaw
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 16, 2021